|
Dako makes disease diagnosis a little more clear-cut. A leader in the area of pathology testing, Dako makes instrumentation systems, reagents, and software used by pathology laboratories to analyze human tissues for the presence of cancer. Its Automated Link line of pathology instruments include staining and visualization systems, chemical and antibody reagents, and Dako Link workflow management software. The company also makes reagents used in flow cytometry testing (which analyzes the cells in blood) and in clinical immunochemistry (which measures proteins in body fluids). The company was acquired by private equity fund EQT in 2007 and subsequently divested its flow cytometry instrumentation business.
|
| | | Contact Information | |
Address: |
Produktionsvej 42
DK-2600 Glostrup, Denmark
| | Phone: | +45-44-85-95-00 | | Fax: | +45-44-85-95-95 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 139.00 M | | Employees (2008): | 1,000 |
|
|
Key People
| | • |
President and CEO:
Patrik Dahlén
| | • |
Corporate VP Operations:
Jorge Cerda
| | • |
CFO:
Per Toelstang
|
|
|
